Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Offers intravenous ketamine infusions for mental health and chronic pain conditions. Reports cite up to a ~70% success rate for certain psychiatric indications. Supplements ketamine with virtual reality-guided meditation to enhance therapeutic outcomes. Not engaged in pharmaceutical R&D or clinical trials as a sponsor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mindscapes.